Skip to main content

Table 1 Baseline characteristics and incidence of CVDs according to the baseline TyG index quartiles

From: Relationship between triglyceride-glucose index baselines and trajectories with incident cardiovascular diseases in the elderly population

Characteristics

Total

Q1(5.7–7.9)

Q2(7.9–8.4)

Q3(8.4–8.7)

Q4(8.7–14.6)

P value

N

20,185

5106

5626

4666

4787

 < 0.001

TyG indexa

8.4 ± 0.6

7.7 ± 0.3

8.2 ± 0.1

8.6 ± 0.1

9.2 ± 0.4

 < 0.001

Age,yearsa

76.9 ± 6.3

77.4 ± 6.2

77.2 ± 6.3

76.7 ± 6.3

76.0 ± 6.2

 < 0.001

Male, n(%)

8411 (41.7)

2807 (55.0)

2315 (41.1)

1752 (37.5)

1537 (32.1)

 < 0.001

BMI, kg/m2a

24.7 ± 4.2

23.2 ± 3.3

24.6 ± 3.4

25.3 ± 3.4

26.0 ± 5.9

 < 0.001

Current smoking, n(%)

13,916 (68.9)

3824 (74.9)

4158 (73.9)

3141 (67.3)

2793 (58.3)

 < 0.001

Current drinking, n(%)

16,768 (83.1)

4956 (97.1)

4931 (87.6)

3671 (78.7)

3210 (67.1)

 < 0.001

Education, n(%)

     

 < 0.001

< High school

18,931 (93.8)

4942 (96.8)

5305 (94.3)

4318 (92.5)

4366 (91.2)

 

High school

878 (4.3)

82 (1.6)

193 (3.4)

245 (5.3)

358 (7.5)

 

> High school

376 (1.9)

82 (1.6)

128 (2.3)

103 (2.2)

63 (1.3)

 

Salt craving, n(%)

876 (4.3)

299 (5.9)

242 (4.3)

191 (4.1)

144 (3.0)

 < 0.001

Oil craving, n(%)

138 (0.7)

45 (0.9)

24 (0.4)

31 (0.7)

38 (0.8)

0.026

SBP, mmHga

117.2 ± 29.0

115.0 ± 18.5

116.4 ± 25.0

117.5 ± 31.5

120.4 ± 38.3

 < 0.001

DBP, mmHga

76.0 ± 15.7

76.6 ± 9.1

76.1 ± 13.3

75.7 ± 17.5

75.3 ± 21.2

 < 0.001

TC, mmol/Lb

5.2 (4.5, 5.9)

4.7 (4.1, 5.4)

5.1 (4.5, 5.8)

5.3 (4.7, 6.0)

5.5 (4.9, 6.3)

 < 0.001

LDL-C, mmol/Lb

2.6 (2.1, 3.1)

2.3 (1.8, 2.9)

2.6 (2.1, 3.1)

2.7 (2.2, 3.2)

2.8 (2.4, 3.3)

 < 0.001

HDL-C, mmol/Lb

1.5 (1.2, 1.7)

1.5 (1.3, 1.7)

1.5 (1.3, 1.7)

1.5 (1.3, 1.7)

1.5 (1.2, 1.7)

 < 0.001

FBG, mmol/La

4.4 ± 1.3

3.9 ± 0.4

4.1 ± 0.5

4.4 ± 0.9

5.3 ± 2.3

 < 0.001

TG, mmol/Lb

1.2 (0.9, 1.7)

0.7 (0.6, 0.9)

1.2 (1.0, 1.3)

1.6 (1.3, 1.8)

2.3 (1.8, 3.0)

 < 0.001

Hypertension,n(%)

5,521 (27.4)

1,040 (20.4)

1,327 (23.6)

1,335 (28.6)

1,819 (38.0)

 < 0.001

Diabetes, n(%)

771 (3.8)

10 (0.2)

39 (0.7)

84 (1.8)

638 (13.3)

 < 0.001

Dyslipidemia, n(%)

5,999 (29.7)

683 (13.4)

977 (17.4)

1171 (25.1)

3168 (66.2)

 < 0.001

CVDs, n(%)

11,099 (55.0)

2567 (50.3)

3176 (56.5)

2611 (56.0)

2745 (57.3)

 < 0.001

RHD, n(%)

60 (0.3)

20 (0.4)

13 (0.2)

12 (0.3)

15 (0.3)

0.447

CHD, n(%)

4170 (20.7)

840 (16.5)

1200 (21.3)

1041 (22.3)

1089 (22.7)

 < 0.001

CVD, n(%)

5598 (27.7)

1304 (25.5)

1613 (28.7)

1302 (27.9)

1379 (28.8)

 < 0.001

PAD, n(%)

984 (4.9)

285 (5.6)

267 (4.7)

212 (4.5)

220 (4.6)

0.055

VTE, n(%)

287 (1.4)

118 (2.3)

83 (1.5)

44 (0.9)

42 (0.9)

 < 0.001

  1. Q1, First Quartile; Q2, Second Quartile; Q3, Third Quartile; Q4, Fourth Quartile; TyG index, triglyceride–glucose index; BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic blood pressure; TC, total cholesterol; HDL-C, high density lipoprotein cholesterol; LDL-C, low density lipoprotein cholesterol; FBG, fasting blood glucose; TG, triglyceride; CVDs, cardiovascular diseases; RHD, rheumatic heart disease; CHD, coronary heart disease; CVD, cerebrovascular disease; PAD, peripheral artery disease; VTE, deep vein thrombosis and pulmonary embolism
  2. aData are mean ± SD
  3. bData are median(IQR)